Integer (ITGR) Stock Price, News & Analysis

Company Overview

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices. Its capabilities span product development, engineering, manufacturing and packaging, supporting customers from early-stage design through commercial production.

The company also supplies specialty batteries and power solutions for selected non-medical markets, including aerospace and defense, energy and other industrial applications. Integer serves customers internationally through manufacturing and development operations in North America, Europe and other global locations. The company was formerly known as Greatbatch, Inc. and adopted the Integer Holdings name in 2016. Thomas J. Miller, Jr. serves as president and chief executive officer.

Key Stats

• Today's Range: $126.30 to $126.45
• 50-Day Range: $93.21 to $126.42
• 52-Week Range: $62.00 to $126.79
• Volume: 64,620 shs
• Average Volume: 771,196 shs
• Market Capitalization: $4.30 billion
• P/E Ratio: 34.52
• Dividend Yield: N/A
• Price Target: $109.86
• Consensus Rating: Hold

Integer Stock Analysis - MarketRank™

Integer scored higher than 56% of companies evaluated by MarketBeat, and ranked 469th out of 900 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.0 / 5
• Analyst Rating: Hold

Consensus Rating

Integer has received a consensus rating of Hold. The company's average rating score is 2.07, and is based on no strong buy ratings, 1 buy rating, 13 hold ratings, and no sell ratings.

Downside Risk

Integer has a consensus price target of $109.86, representing about 13.1% downside from its current price of $126.40.

Amount of Analyst Coverage

Integer has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 10.18%

Earnings Growth

Earnings for Integer are expected to grow by 10.18% in the coming year, from $6.09 to $6.71 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Integer is 34.54, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.97.

Price to Earnings Ratio vs. Sector

The P/E ratio of Integer is 34.54, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 273.33.

Price to Earnings Growth Ratio

Integer has a PEG Ratio of 2.40. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Integer has a P/B Ratio of 2.54. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.72% of the float of Integer has been sold short.

Short Interest Ratio / Days to Cover

Integer has a short interest ratio ("days to cover") of 3.89, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Integer has recently decreased by 8.96%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Integer does not currently pay a dividend.

Dividend Growth

Integer does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.50

News Sentiment

Integer has a news sentiment score of 0.50. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.80 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Integer this week, compared to 9 articles on an average week.

MarketBeat Follows

Only 1 people have added Integer to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Integer insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,169,920.00 in company stock.

Percentage Held by Insiders

1.10% of the stock of Integer is held by insiders.

Percentage Held by Institutions

99.29% of the stock of Integer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/03/2026
• Today: 9/18/2026
• Next Earnings (Estimated): 10/22/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Equipment & Supplies
• Sub-Industry: Healthcare Equipment
• Current Symbol: NYSE:ITGR
• Previous Symbol: NASDAQ:ITGR
• CIK: 1114483
• Web: www.integer.net
• Phone: (214) 618-5243
• Fax: 716-759-5654
• Employees: 11,000
• Year Founded: 1940

Price Target and Rating

• Average Price Target for Integer: $109.86
• High Price Target: $127.00
• Low Price Target: $87.00
• Potential Upside/Downside: -13.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.07
• Research Coverage: 14 Analysts

Profitability

• EPS (Trailing Twelve Months): $3.66
• Trailing P/E Ratio: 34.53
• Forward P/E Ratio: 20.75
• P/E Growth: 2.4
• Net Income: $102.81 million
• Net Margins: 6.97%
• Pretax Margin: 7.40%
• Return on Equity: 12.79%
• Return on Assets: 6.48%

Debt

• Debt-to-Equity Ratio: 0.75
• Current Ratio: 3.73
• Quick Ratio: 2.41

Sales & Book Value

• Annual Sales: $1.85 billion
• Price / Sales: 2.32
• Cash Flow: $10.38 per share
• Price / Cash Flow: 12.17
• Book Value: $49.85 per share
• Price / Book: 2.54

Miscellaneous

• Outstanding Shares: 34,000,000
• Free Float: 33,623,000
• Market Cap: $4.30 billion
• Optionable: Optionable
• Beta: 0.62